• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的细胞介导免疫

Cell-mediated immunity to SARS-CoV-2.

作者信息

Wang Xiaolin, Gui Jingang

机构信息

Laboratory of Tumor Immunology Beijing Pediatric Research Institute Beijing Children's Hospital Capital Medical University National Center for Children's Health Beijing China.

出版信息

Pediatr Investig. 2020 Dec 28;4(4):281-291. doi: 10.1002/ped4.12228. eCollection 2020 Dec.

DOI:10.1002/ped4.12228
PMID:33376956
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7768298/
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viruses spread unscrupulously virtually every corner on the planet in a very quick speed leading to an unprecedented world pandemic of COVID-19 claiming a great many of people's life. Paramount importance has been given to the studies on the virus itself including genomic variation and viron structure, as well as cell entry pathway and tissue residence. Other than that, to learn the main characteristic of host immunity responding to SARS-CoV-2 infection is an eminent task for restraining virus and controlling disease progress. Beside antibody production in response to SARS-CoV-2 infection, host cellular immunity plays an indispensable role in impeding virus replication and expansion at various stages of COVID-19 disease. In this review, we summarized the recent knowledge regarding the aberrant regulation and dysfunction of multiple immune cells during SARS-CoV-2 infection. This includes the dysregulation of immune cell number, Th polarity, cytokine storm they implicated with, as well as cell function exhaustion after chronic virus stimulation. Notwithstanding that many obstacles remain to be overcome, studies on immunotherapy for COVID-19 treatment based on the known features of host immunity in response to SARS-CoV-2 infection offer us tangible benefits and hope for making this SARS-CoV-2 pandemic under control.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)以极快的速度肆无忌惮地传播到地球上几乎每一个角落,导致了前所未有的新型冠状病毒肺炎(COVID-19)全球大流行,夺走了许多人的生命。对该病毒本身的研究,包括基因组变异、病毒体结构、细胞进入途径和组织驻留等,已被赋予了至关重要的地位。除此之外,了解宿主免疫对SARS-CoV-2感染的主要特征是抑制病毒和控制疾病进展的一项重要任务。除了针对SARS-CoV-2感染产生抗体外,宿主细胞免疫在COVID-19疾病的各个阶段阻碍病毒复制和扩散中起着不可或缺的作用。在这篇综述中,我们总结了关于SARS-CoV-2感染期间多种免疫细胞异常调节和功能障碍的最新知识。这包括免疫细胞数量的失调、Th极性、与之相关的细胞因子风暴,以及慢性病毒刺激后细胞功能耗竭。尽管仍有许多障碍有待克服,但基于宿主免疫对SARS-CoV-2感染的已知特征进行的COVID-19治疗免疫疗法研究为我们控制这场SARS-CoV-2大流行带来了切实的益处和希望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a460/7768298/03c49e17cd01/PED4-4-281-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a460/7768298/03c49e17cd01/PED4-4-281-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a460/7768298/03c49e17cd01/PED4-4-281-g001.jpg

相似文献

1
Cell-mediated immunity to SARS-CoV-2.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的细胞介导免疫
Pediatr Investig. 2020 Dec 28;4(4):281-291. doi: 10.1002/ped4.12228. eCollection 2020 Dec.
2
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.SARS-CoV-2 感染免疫功能低下患者:体液免疫与细胞免疫。
J Immunother Cancer. 2020 Jul;8(2). doi: 10.1136/jitc-2020-000862.
3
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
4
Adaptive Immunity to Viruses: What Did We Learn from SARS-CoV-2 Infection?病毒的适应性免疫:我们从 SARS-CoV-2 感染中学到了什么?
Int J Mol Sci. 2022 Nov 12;23(22):13951. doi: 10.3390/ijms232213951.
5
Innate immunity, cytokine storm, and inflammatory cell death in COVID-19.COVID-19 中的固有免疫、细胞因子风暴和炎症细胞死亡。
J Transl Med. 2022 Nov 22;20(1):542. doi: 10.1186/s12967-022-03767-z.
6
The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy.严重急性呼吸综合征冠状病毒 2 感染对固有免疫的调节作用及抗击 COVID-19 炎症反应的治疗策略。
J Biomed Sci. 2022 May 3;29(1):27. doi: 10.1186/s12929-022-00811-4.
7
Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.托珠单抗治疗细胞因子风暴综合征的 SARS-CoV-2 患者:一项叙述性综述。
Rev Recent Clin Trials. 2021;16(2):138-145. doi: 10.2174/1574887115666200917110954.
8
A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.基于网络的分析揭示了维生素 D 抑制 SARS-CoV-2 感染中细胞因子风暴和病毒的机制。
Front Immunol. 2020 Dec 9;11:590459. doi: 10.3389/fimmu.2020.590459. eCollection 2020.
9
How does the Immunological System Change during the SARS-COV-2 Attack? A Clue for the New Immunotherapy Discovery.在新冠病毒攻击期间免疫系统如何变化?新免疫疗法发现的线索。
Curr Med Chem. 2023 Sep 18. doi: 10.2174/0929867331666230918092749.
10
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).关于冠状病毒病 (COVID-19) 期间免疫反应和衰竭的综合综述。
Cell Commun Signal. 2022 Jun 2;20(1):79. doi: 10.1186/s12964-022-00856-w.

引用本文的文献

1
Circulating fibroblasts present neutrophil-like features in severe COVID-19 cases revealed by single-cell landscape analyses.单细胞图谱分析揭示,在重症新冠病毒肺炎病例中,循环成纤维细胞呈现出中性粒细胞样特征。
Genes Dis. 2023 Mar 27;10(6):2233-6. doi: 10.1016/j.gendis.2023.02.032.
2
Immunology of Multisystem Inflammatory Syndrome after COVID-19 in Children: A Review of the Current Evidence.儿童 COVID-19 后多系统炎症综合征的免疫学:当前证据综述。
Int J Mol Sci. 2023 Mar 16;24(6):5711. doi: 10.3390/ijms24065711.
3
Natural killer cells in COVID-19: from infection, to vaccination and therapy.

本文引用的文献

1
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates.SARS-CoV-2 免疫:综述及对 3 期疫苗候选物的应用。
Lancet. 2020 Nov 14;396(10262):1595-1606. doi: 10.1016/S0140-6736(20)32137-1. Epub 2020 Oct 13.
2
Single cell sequencing unraveling genetic basis of severe COVID19 in obesity.单细胞测序揭示肥胖中重症 COVID-19 的遗传基础。
Obes Med. 2020 Dec;20:100303. doi: 10.1016/j.obmed.2020.100303. Epub 2020 Sep 24.
3
Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.
新冠病毒疾病中的自然杀伤细胞:从感染到疫苗接种及治疗
Future Virol. 2023 Feb. doi: 10.2217/fvl-2022-0040. Epub 2023 Mar 14.
4
Exploring the Role of Immune System and Inflammatory Cytokines in SARS-CoV-2 Induced Lung Disease: A Narrative Review.探索免疫系统和炎性细胞因子在SARS-CoV-2诱导的肺部疾病中的作用:一项叙述性综述
Biology (Basel). 2023 Jan 22;12(2):177. doi: 10.3390/biology12020177.
5
Identification and characterization of a novel cell binding and cross-reactive region on spike protein of SARS-CoV-2.鉴定和表征新型 SARS-CoV-2 刺突蛋白上的细胞结合和交叉反应区域。
Sci Rep. 2022 Sep 19;12(1):15668. doi: 10.1038/s41598-022-19886-y.
6
COVID-19 vs. Cancer Immunosurveillance: A Game of Thrones within an Inflamed Microenviroment.新冠病毒与癌症免疫监视:炎症微环境中的权力游戏。
Cancers (Basel). 2022 Sep 5;14(17):4330. doi: 10.3390/cancers14174330.
7
Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update.奥密克戎变异株流行背景下需要加强疫苗接种以应对 SARS-CoV-2 变异株的出现和 COVID-19 病例增加:更新。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2065824. doi: 10.1080/21645515.2022.2065824. Epub 2022 May 20.
8
Humoral response to viral vector COVID-19 vaccine in hemodialysis patients.血液透析患者对新冠病毒载体疫苗的体液免疫反应。
Kidney Res Clin Pract. 2022 May;41(3):342-350. doi: 10.23876/j.krcp.21.184. Epub 2022 Mar 3.
9
The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication.新型冠状病毒病肺外并发症的发病机制及其治疗意义。
Signal Transduct Target Ther. 2022 Feb 23;7(1):57. doi: 10.1038/s41392-022-00907-1.
10
EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes.EpiCurator:一种预测和排序新冠病毒2型表位的免疫信息学工作流程。
PeerJ. 2021 Nov 30;9:e12548. doi: 10.7717/peerj.12548. eCollection 2021.
SARS-CoV-2 感染期间的固有免疫:逃逸策略和激活触发缺氧和血管损伤。
Clin Exp Immunol. 2020 Nov;202(2):193-209. doi: 10.1111/cei.13523. Epub 2020 Oct 12.
4
T-cell responses and therapies against SARS-CoV-2 infection.T 细胞应答与针对 SARS-CoV-2 感染的治疗方法。
Immunology. 2021 Jan;162(1):30-43. doi: 10.1111/imm.13262. Epub 2020 Oct 27.
5
Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition.分析 SARS-CoV-2 刺突蛋白糖罩揭示了对免疫识别的影响。
Sci Rep. 2020 Sep 14;10(1):14991. doi: 10.1038/s41598-020-71748-7.
6
Broad and strong memory CD4 and CD8 T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.在 COVID-19 之后,英国康复个体中 SARS-CoV-2 诱导产生的广泛而强大的记忆性 CD4 和 CD8 T 细胞。
Nat Immunol. 2020 Nov;21(11):1336-1345. doi: 10.1038/s41590-020-0782-6. Epub 2020 Sep 4.
7
Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients.在重症 COVID-19 患者中非常规 T 细胞的表型和功能改变。
J Exp Med. 2020 Dec 7;217(12). doi: 10.1084/jem.20200872.
8
A dynamic COVID-19 immune signature includes associations with poor prognosis.一个动态的 COVID-19 免疫特征包括与预后不良的关联。
Nat Med. 2020 Oct;26(10):1623-1635. doi: 10.1038/s41591-020-1038-6. Epub 2020 Aug 17.
9
Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.急性严重急性呼吸综合征冠状病毒 2 感染损害树突状细胞和 T 细胞应答。
Immunity. 2020 Oct 13;53(4):864-877.e5. doi: 10.1016/j.immuni.2020.07.026. Epub 2020 Aug 4.
10
COVID-19: The Immune Responses and Clinical Therapy Candidates.新型冠状病毒肺炎:免疫应答与临床治疗候选药物。
Int J Mol Sci. 2020 Aug 3;21(15):5559. doi: 10.3390/ijms21155559.